Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Compounds that appeared promising in preclinical and early clinical data have failed in later-phase trials repeatedly
Among the 14 identified candidates, acetylcarnitine was finally selected by confirming whether it was endogenous in the blood, matched with the mass value, and exhibited a significant difference in intensity between the MDD and control groups (Figure 4)
10.1016/j.diabres.2005.10.007 19
Responden rpidamente a cualquier pregunta o inquietud que tenga
About the Supplier This supplier has been audited by CTI
US$ 26.75
US$ 28.42
US$ 26.51
US$ 23.43
